Stocks in play: Satellos Bioscience Inc.
Today announced that Frank Gleeson, Satellos CEO, will join leading members of the Duchenne medical and scientific community during a panel discussion at PPMD's 30th Annual Conference being held from June 27–29, 2024 in Orlando, Florida. Satellos Bioscience Inc. shares T.MSCL are trading unchanged at $0.52.
Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.